Skip to content
Saturday, March 15, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
13
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial – Pharmacy Times
GLP-1 News
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial – Pharmacy Times
March 13, 2025
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial
Pharmacy Times
Post navigation
Vivani reports first human GLP-1 implant for weight loss in adults – Drug Delivery Business News
‘RuPaul’s Drag Race’ Star Peppermint Lost 100 Lbs. with Weight-Loss Injections – PEOPLE